Koomesh
Journal of Semnan University of Medical Sciences
B-cell chronic lymphocyte leukemia (B-CLL)
Parviz Kokhaei,*Abstract
The past two decades have seen a major progress in the filed of pathphysiology and treatment of chronic lymphocytic leukemia (CLL). New findings suggested that CLL comprises two separate types of tumor with different prognosis outcome. CLL formerly was considered an incurable ‘‘oldman’s disease’’ caused by slowly accumulating, incompetent lymphocytes. Because elderly patients were expected to die with CLL rather than from it, the mainstay of therapy was to palliate symptoms with oral, alkylating drugs, such as chlorambucil. However, treatment with such drugs not only could not cure the disease, but also could shorten survival if given to patients with early-stage disease. This article summarizes some of the recent advances that have shaped a new way of thinking about this disease including epidemiology, diagnosis and prognostic factors. Treatment strategies, chemotherapy, monoclonal antibodies have been briefly discussed.
Copyright
© 2007, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
New Developments in Chronic Myeloid Leukemia: Implications for Therapy
Tabarestani S, Movafagh A. New Developments in Chronic Myeloid Leukemia: Implications for Therapy. Int J Cancer Manag. 2016;9(1):e3961. doi: https://doi.org/10.17795/ijcp-3961
Simultaneous Occurrence of B-Cell Lymphocytic Leukemia and Acute Myeloid Leukemia in an Elderly Female Patient
Sadeghi M, Allahyari A, Esfandiari N, Nazemian F. Simultaneous Occurrence of B-Cell Lymphocytic Leukemia and Acute Myeloid Leukemia in an Elderly Female Patient. Int J Cancer Manag. 2017;10(2):e4930. doi: https://doi.org/10.5812/ijcp.4930
Somatic Mutation in Immunoglobulin Gene Variable Region in Patients With Chronic Lymphoid Leukemia and Its Influence on Disease Prognosis
Sadighi S, Jahanzad I, Mohagheghi MA, Shokrollahi Barough M, Hojjat-Farsangi M, et al. Somatic Mutation in Immunoglobulin Gene Variable Region in Patients With Chronic Lymphoid Leukemia and Its Influence on Disease Prognosis. Middle East J Rehabil Health Stud. 2016;3(2):e35848. doi: https://doi.org/10.17795/mejrh-35848
Cholorambucil versus Cholorambucil Plus Prednisolone as First-Line Therapy of Chronic Lymphocytic Leukemia in West of Iran
Payandeh M, Sadeghi M, Sadeghi E. Cholorambucil versus Cholorambucil Plus Prednisolone as First-Line Therapy of Chronic Lymphocytic Leukemia in West of Iran. Int J Cancer Manag. 2015;8(2):e80597. doi:
A Case of Type 1 Gaucher’s Disease Associated with Nonhodgkin Lymphoma
Eishi Oskuie A, Valizadeh N, Ilkhanizadeh B. A Case of Type 1 Gaucher’s Disease Associated with Nonhodgkin Lymphoma. Shiraz E-Med J. 2010;11(2):e93802. doi:
- Scopus by DOI: 0
Last Update: 0 months ago
- Scopus by Title: 3
Last Update: 0 months ago
- Scopus by Title (Ref): 0
Last Update: 0 months ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC